Company profile

Abacus Bioscience company profile

Abacus Bioscience specializes in developing immunotherapies for treating chronic infectious diseases and cancers. It provides a broad-based platform that can plug and play with multiple cancer or viral antigens. The company was founded in 2017 and is headquartered in Seattle, Washington.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2017-01-01

Headquarters

Headquarters
Seattle, United States, Washington
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$4.4M
Last funding
Seed / $4.4M / 2023-02-01
Last equity funding
Seed / $4.4M
Investors
1
Lead investors
1
Founders
1
Articles
5

Founders and investors

Founders

Craig Philips

Lead investors

Seagen

Investors

Seagen

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.